LUCERNA INC
- LOS ANGELES, CA 90045-3207
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
- Women-Owned Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
LUCERNA INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About LUCERNA INC
- Headquarters
- LOS ANGELES, CA 90045-3207
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIJ3MWGA6WFCG3
- CAGE5XRS8
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 22 awards
- Total awarded
- $10,266,039
- By phase
- SBIR Phase I: 18
- SBIR Phase II: 4
- By agency
- Department of Health and Human Services: 21
- National Science Foundation: 1
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2025: 1
- 2024: 2
- 2022: 1
- 2020: 2
- 2019: 2
- 2018: 5
- 2017: 1
- 2016: 1
- 2014: 2
- 2013: 2
- 2012: 2
- 2011: 1
Awards (most recent first)
In vivo imaging platform for DM1 drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $313,148
Aug 1, 2025 – Jul 31, 2026
Solicitation PA24-245 (2024) · Topic NIAMS
Targeted RNA degradation assay for new antiviral drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $300,000
Aug 1, 2024 – Jul 31, 2025
Solicitation PA23-230 (2023) · Topic NIAID
Cell-based RNA degradation assay for C9ALS/FTD drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $392,116
Dec 1, 2023 – Nov 30, 2024
Solicitation PAS22-196 (2022) · Topic NIA
Fluorescent IRE sensor for synucleinopathy drug discovery
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $1,728,231
Sep 22, 2022 – Aug 31, 2024
- Direct to Phase II
Solicitation PAS19-316 (2019) · Topic 105
Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $223,700
Apr 1, 2020 – Mar 31, 2021
Solicitation PA19-272 (2019) · Topic 100
Cell-based assay directly monitoring viral polymerase activity for drug discovery.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $224,323
Dec 5, 2019 – Nov 30, 2020
Solicitation PA18-574 (2018) · Topic NIAID
New high-throughput screening technologies to improve cannabinoid production in yeast.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $224,928
Dec 1, 2018 – Nov 30, 2020
Solicitation PA18-574 (2018) · Topic NCCIH
TOPIC 356: FLUOROGENIC ASSAY PLATFORM FOR CIRCULAR RNA DETECTION
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2019 · $1,480,983
Solicitation year 2018 · Topic NCI
Assay Classifier Engine (ACE) for enhancing splice sensor assay performance
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $224,925
Aug 1, 2018 – Jul 31, 2019
Solicitation PA17-302 (2017) · Topic 400
Fluorescent IRE sensor for PD drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $221,896
Jul 1, 2018 – Jun 30, 2019
Solicitation PA17-302 (2017) · Topic NIA
Cell-based viral helicase assay for dengue drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $224,475
Jul 1, 2018 – Jun 30, 2019
Solicitation PA17-302 (2017) · Topic NIAID
Splice sensors for cancer drug discovery
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $1,491,344
Apr 1, 2018 – Mar 31, 2021
Solicitation PA17-302 (2017) · Topic 102
TOPIC 356: FLOUROGENIC ASSAY PLATFORM FOR CIRCULAR RNA DETECTION
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $49,973
Solicitation year 2016 · Topic NCI
Fluorescent reporters for real time single cell Pol III transcription measurement
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $176,165
Feb 1, 2017 – Jan 31, 2019
Solicitation PA15-269 (2015) · Topic 400
Splice sensors for cancer drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $224,251
Jul 5, 2016 – Jun 30, 2018
Solicitation PA15-269 (2015) · Topic 102
New toolkit to visualize RNAs in living cells
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $1,248,733
Jul 1, 2014 – Jun 30, 2018
Solicitation PA11-134 (2011) · Topic 101
Fluorescent RNA foci assay for FXTAS drug discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $207,922
Solicitation PA13-088 (2014) · Topic NCATS · Research partner: Stub
SBIR Phase I: Live-cell metabolite sensors for improving biofuel production
SBIR Phase I · National Science Foundation · 2013 · $149,733
Jul 1, 2013 – Jun 30, 2014
Solicitation year 2012 · Topic BC · Research partner: Stub
Live-Cell Assays of ER and Golgi Enzyme Activities
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $298,937
Solicitation PA11-335 (2013) · Topic NIGMS · Research partner: Stub
Methyltransferease sensors for homogenous HTS assays
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $216,247
Solicitation PA11-096 (2012) · Topic NIGMS · Research partner: Stub
New toolkit to visualize RNAs in living cells
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $315,412
Solicitation PA11-134 (2012) · Topic NIMH · Research partner: Stub
Clozapine Sensors for Improving Therapeutic Treatments of Schizophrenia
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $328,597
Solicitation PA08-142 (2011) · Topic NIMH · Research partner: Stub
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Socio-economic status
Self-represented in SAM.gov. WOSB and EDWOSB set-asides need SBA certification (13 CFR 127.300); SDVOSB and VOSB need SBA VetCert (13 CFR part 128). Confirm current certification before relying on it.
Learn more about small business set-asidesProduct & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with LUCERNA INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.